← Back to Vaccine Database

Gam-COVID-Vac Adeno-based (rAd26-S+rAd5-S)

Viral vector (Non-replicating) vaccine · VDDBV0278

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials17

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04436471 Phase 2COVID-19
NCT04437875 Phase 2COVID-19
NCT04713488 Phase 2COVID-19
NCT04760730 Phase 2COVID-19
NCT05248373 Phase 2COVID-19
NCT04962906 Phase 2COVID-19
NCT05027672 Phase 2COVID-19
NCT04587219 Phase 2COVID-19
NCT04962906 Phase 2COVID-19
NCT04983537 Phase 2COVID-19
NCT04988048 Phase 2COVID-19
NCT04640233 Phase 3COVID-19
NCT04530396 Phase 3COVID-19
NCT04564716 Phase 3COVID-19
NCT04642339 Phase 3COVID-19
NCT04656613 Phase 3COVID-19
NCT04741061 Phase 3COVID-19